Oncogeriatrics: There is a tomorrow;Oncogériatrie: Le quotidien de demain

Revue de Geriatrie

Volumn 26, Issue 4, 2001, Pages 271-282

  Auclerc, G ^a   Spano, J P ^a   Brunet Pommeyrol, A ^a   Antoine, E C ^a   Khayat, D ^a  

^a Service d'Informatique Medicale   (France)

Author keywords

Chemotherapy; Hormone therapy; Life expectancy; Oncogeriatrics; Pharmacocinetics; Protocol

Indexed keywords

AMIFOSTINE; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; HORMONE; PROGESTERONE RECEPTOR; RAZOXANE; RECOMBINANT ERYTHROPOIETIN; TAMOXIFEN;

AGING; CLINICAL TRIAL; GERIATRICS; HUMAN; LIFE EXPECTANCY; MALIGNANT NEOPLASTIC DISEASE; NEPHROTOXICITY; PROGNOSIS; REVIEW;

EID: 0034966164     PISSN: 03977927     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Cancer in older persons. Magnitude of the problem. How do we apply what we know?
2. Co-morbidity and functional status are independent in older cancer patients
3. Screening for cancer in the elderly
4. A retrospective comparison of detection and treatment of breast cancer in young and elderly patients
5. Cancer chemotherapy in the older patients
6. Cancer pharmacology in the elderly
7. Age and sex are independent predictors of 5-fluorouracil toxicity: Analysis of a large scale phase III trial
8. Chimiothérapies cytotoxiques et sujets âgés: Constats et perspectives
9. Geriatric pharmacology: Basic and clinical consideration
10. Cyclophosphamide, methotrexate, and 5flucrouracil chemotherapy in women more than 65 years old with advanced breast cancer: The elimination of age trends in toxicity by using doses based on creatinine clearance
11. Difficulties in treating older patients with cancer
12. Patterns of breast cancer care in elderly
13. Cancer du sein de la femme âgée
14. Are the elderly receiving appropricite treatment for cancer?
15. Cancer treatment and age: Patient perspectives
16. Denying surgery to elderly people with cancer
17. Determinant of cancer therapy in elderly patients
18. Determinants of survival in older cancer patients
19. Toxicity and therapeutic response to chemotherapy in patients aged 70 years or older with advanced cancer
20. The role of chemotherapy and adjuvant therapy in the management of breast cancer in older women
21. Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis examining total and active life-expectancy outcomes
22. Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision analysis model
23. Advanced colorectal cancer in the elderly: Results of consecutive trials with 5-fluorouracilbased chemotherapy
24. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older
25. Clinical trials and drugs toxicity in the elderly
26. Treatment tolerance of elderly cancer patients entered onto Phase II clinical trials: An Illinois cancer center study
27. CHOP is the standard regimen in patients of 70 years of age or more with intermediate and high grade non-Hodgkin lymphomas: Results of a randomized study
28. Trends in breast cancer in younger women in contrast to older women
29. Breast cancer in older women
30. Surgical resection plus tamoxifen as treatment of breast cancer in elderly patients: A retrospective study
31. Adjuvant tamoxifen versus placebo in elderly women with node positive breast cancer: Long term follow-up and causes of death
32. Systemic treatment for early breast cancer by hormonal, cytotoxic or immune therapy, 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women
33. Dose and dose intensity of adjuvant chemotherapy for stage II node positive breast carcinoma
34. Traitement initial par tamoxifène (Nolvadex) des cancers primitifs du sein après 65 ans. A propos d'une étude multicentrique sur 78 cas
35. Assessment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer
36. Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5 Year follow-up
37. Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone
38. Tamoxifen versus surgery plus tamoxifen as primary treatment of elderly patients vàth breast cancer: Combined data from the GRETA and CRC trials
39. Chimiothérapie néoadjuvante dans les cancers primitifs du sein après 70 ans
40. An assessment of treatment options for breast conservation in the elderly woman with early stage breast cancer
41. Meeting highlands: Adjuvant therapy for primary breast cancer
42. Assessment of biological age by principal component analys ech